Takeda is a research-based global company with its main focus on pharmaceuticals. Takeda has an active commercial presence in the therapeutic areas of metabolic diseases, gastroenterology, oncology, cardiovascular health, CNS diseases, inflammatory and immune disorders, respiratory diseases and pain…
Takeda is a research-based global company with its main focus on pharmaceuticals. Takeda has an active commercial presence in the therapeutic areas of metabolic diseases, gastroenterology, oncology, cardiovascular health, CNS diseases, inflammatory and immune disorders, respiratory diseases and pain management. Takeda's has a major commercial presence in North America, Japan, Asia, Europe, and the high growth emerging markets. The company has a presence in more than 70 countries worldwide, and is ranked 12th by global Rx sales, 14th in the BRIC countries and 18th in Europe. As the largest pharmaceutical company in Japan and one of the global leaders of the industry, Takeda is committed to strive towards better health for patients worldwide through leading innovation in medicine.
Team (2)
Sectors Takeda Pharmaceuticals serves:
Life Sciences
Join Axial's Private M&A Platform
Takeda Pharmaceuticals connects with qualified M&A advisors through the Axial Platform.
Looking for Buyers?
Reach this investor and hundreds more on Axial. No cost to advisors.
